drugset / Trial / NCT01151605
The Suppression of Toll Like Receptors by Insulin
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study will help us understand the possible beneficial effects of insulin in inflammation. Inflamamtion is considered to be the cause of atherosclerosis and heart disease.
Timeline
- Start
- 2008-09
- Primary completion
- 2012-07
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 3.5 iu | Intravenous |
| Background | Dextrose | Unknown | 12.5 % | Intravenous |
Indications
No indication recorded.